Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  HIV Infection

  Free Subscription


18.01.2010

7 AIDS
13 AIDS Res Hum Retroviruses
3 Arch Intern Med
3 Clin Infect Dis
7 HIV Med
1 Immunology
4 J Acquir Immune Defic Syndr
1 J Immunol
2 J Infect Dis
4 J Virol
1 Pediatr Infect Dis J
3 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. PRENDERGAST A , Prado JG, Kang YH, Chen F, et al
    HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells.
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available

  2. NDIRANGU J , Newell ML, Tanser F, Herbst AJ, et al
    Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact?
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available

  3. NATHAN M , Singh N, Garrett N, Hickey N, et al
    Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings.
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. Late diagnosis in the HAART era: proposed common definitions and associations with mortality.
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available

  5. POVEDA E , Anta L, Blanco JL, Perez-Elias MJ, et al
    Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available

  6. MARTINEZ E , Visnegarwala F, Grund B, Thomas A, et al
    The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters.
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available

  7. HUDELSON SE , McConnell MS, Bagenda D, Piwowar-Manning E, et al
    Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.
    AIDS. 2010.
    PubMed     Text format     Related articles    Abstract available


    AIDS Res Hum Retroviruses

  8. GUPTA A , Saple DG, Nadkarni G, Shah B, et al
    One-, Two-, and Three-Class Resistance among HIV-Infected Patients on Antiretroviral Therapy in Private Care Clinics: Mumbai, India.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  9. TSUI SK , Fong NY, Li SK, Leung KK, et al
    Full Genome Analysis of an Emerging Cluster of Human Immunodeficiency Virus Type 1 Subtype B Infection in Hong Kong.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  10. WEI X , Liu X, Dobbs T, Kuehl D, et al
    Development of Two Avidity-Based Assays to Detect Recent HIV Type 1 Seroconversion Using a Multisubtype gp41 Recombinant Protein.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  11. WILLEY R , Nason MC, Nishimura Y, Follmann DA, et al
    Neutralizing Antibody Titers Conferring Protection to Macaques from a Simian/Human Immunodeficiency Virus Challenge Using the TZM-bl Assay.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  12. WEINBERG A , Song LY, Fenton T, Nachman SA, et al
    T Cell Responses of HIV-Infected Children after Administration of Inactivated or Live Attenuated Influenza Vaccines.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  13. VALLARI A , Bodelle P, Ngansop C, Makamche F, et al
    Four New HIV-1 Group N Isolates from Cameroon: Prevalence Continues to Be Low.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  14. VALENTIN A , Morrow M, Poirier RH, Aleman K, et al
    Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4(+) Primary Cells.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  15. TILTON JC , Amrine-Madsen H, Miamidian JL, Kitrinos KM, et al
    HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  16. ARROYO MA , Phanuphak N, Krasaesub S, Sirivichayakul S, et al
    HIV Type 1 Molecular Epidemiology among High-Risk Clients Attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  17. ARRUDA LB , Fonseca LA, Duarte AJ, Casseb J, et al
    Genetic Diversity on the Integrase Region of the pol Gene among HIV Type 1-Infected Patients Naive for Integrase Inhibitors in Sao Paulo City, Brazil.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  18. JOHNSTON R , Collins C
    Can We Treat Our Way Out of HIV?
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  19. RIVA C , Lai A, Caramma I, Corvasce S, et al
    Transmitted HIV Type 1 Drug Resistance and Non-B Subtypes Prevalence among Seroconverters and Newly Diagnosed Patients from 1992 to 2005 in Italy.
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available

  20. V A M , A V M, S L
    Short Communication: Simultaneous Substitutions of V38M and N43T-N44K in the gp41 Heptad Repeat 1 (HR1) Disrupt HIV Type 1 gPr160 Endoproteolytic Cleavage (*).
    AIDS Res Hum Retroviruses. 2010.
    PubMed     Text format     Related articles    Abstract available


    Arch Intern Med

  21. PATEL P , Mackellar D, Simmons P, Uniyal A, et al
    Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
    Arch Intern Med. 2010;170:66-74.
    PubMed     Text format     Related articles    Abstract available

  22. ELZI L , Marzolini C, Furrer H, Ledergerber B, et al
    Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
    Arch Intern Med. 2010;170:57-65.
    PubMed     Text format     Related articles    Abstract available

  23. KATZ MH
    HIV/AIDS 2010: Better drugs, better technologies, and lingering problems.
    Arch Intern Med. 2010;170:6-8.
    PubMed     Text format     Related articles   


    Clin Infect Dis

  24. TUBIANA R , Le Chenadec J, Rouzioux C, Mandelbrot L, et al
    Factors Associated with Mother-to-Child Transmission of HIV-1 Despite a Maternal Viral Load <500 Copies/mL at Delivery: A Case-Control Study Nested in the French Perinatal Cohort (EPF-ANRS CO1).
    Clin Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available

  25. ROUTMAN JS , Willig JH, Westfall AO, Abroms SR, et al
    Comparative Efficacy versus Effectiveness of Initial Antiretroviral Therapy in Clinical Trials versus Routine Care.
    Clin Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available

  26. DEL PALACIO A , Llenas-Garcia J, Soledad Cuetara M, Pulido F, et al
    Serum (1-->3) beta-D-Glucan as a noninvasive adjunct marker for the diagnosis and follow-up of pneumocystis jiroveci pneumonia in patients with HIV infection.
    Clin Infect Dis. 2010;50:451-2.
    PubMed     Text format     Related articles   


    HIV Med

  27. FABBIANI M , Di Giambenedetto S, Ragazzoni E, Colafigli M, et al
    Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  28. PARCZEWSKI M , Leszczyszyn-Pynka M, Wnuk A, Urbanska A, et al
    Introduction of pharmacogenetic screening for the human leucocyte antigen (HLA) B*5701 variant in Polish HIV-infected patients.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  29. BROOK G , Main J, Nelson M, Bhagani S, et al
    British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010.
    HIV Med. 2010;11:1-30.
    PubMed     Text format     Related articles   

  30. BOER K , England K, Godfried MH, Thorne C, et al
    Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  31. RAMSETTY SK , Stuart LL, Blake RT, Parsons CH, et al
    Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  32. SZCZECH LA , Menezes P, Byrd Quinlivan E, van der Horst C, et al
    Microalbuminuria predicts overt proteinuria among patients with HIV infection.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available

  33. CADE WT , Reeds DN, Mondy KE, Overton ET, et al
    Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available


    Immunology

  34. MARTINEZ-NAVIO JM , Climent N, Pacheco R, Garcia F, et al
    Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
    Immunology. 2009;128:393-404.
    PubMed     Text format     Related articles    Abstract available


    J Acquir Immune Defic Syndr

  35. CRAWFORD KW , Li C, Keung A, Su Z, et al
    Pharmacokinetic/Pharmacodynamic Modeling of the Antiretroviral Activity of the CCR5 Antagonist Vicriviroc in Treatment Experienced HIV-Infected Subjects (ACTG Protocol 5211).
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available

  36. CHANG TL , Klepper A, Ding J, Garber J, et al
    Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of Human Immunodeficiency Virus Type 1 Isolates.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available

  37. KATZ IT , Shapiro R, Li D, Govindarajulu U, et al
    Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women and Infants Transmission Study.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available

  38. HURT CB , Matthews DD, Calabria MS, Green KA, et al
    Sex with Older Partners Is Associated With Primary HIV Infection Among Men Who Have Sex With Men in North Carolina.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available


    J Immunol

  39. BOULET S , Song R, Kamya P, Bruneau J, et al
    HIV Protective KIR3DL1 and HLA-B Genotypes Influence NK Cell Function Following Stimulation with HLA-Devoid Cells.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available


    J Infect Dis

  40. SULEIMAN J , Zingman BS, Diaz RS, Madruga JV, et al
    Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment-Experienced Subjects: 48-Week Results of the VICTOR-E1 Phase 2 Trial.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available

  41. HERBECK JT , Gottlieb GS, Winkler CA, Nelson GW, et al
    Multistage Genomewide Association Study Identifies a Locus at 1q41 Associated with Rate of HIV-1 Disease Progression to Clinical AIDS.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available


    J Virol

  42. GORDON SN , Weissman AR, Cecchinato V, Fenizia C, et al
    Pre-existing Infection with Human T-cell Lymphotropic Virus Type 2 neither Exacerbate nor Attenuate SIVmac251 Infection in macaques.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available

  43. VAN GILS MJ , Bunnik EM, Burger JA, Jacob Y, et al
    Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term non-progressors.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available

  44. PUSHKER R , Jacque JM, Shields DC
    Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available

  45. ALLERS K , Loddenkemper C, Hofmann J, Unbehaun A, et al
    Gut Mucosal FOXP3+ Regulatory CD4+ T Cells and Non-Regulatory CD4+ T Cells are Differentially Affected by SIV Infection in Rhesus Macaques.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available


    Pediatr Infect Dis J

  46. MORROW BM , Hsaio NY, Zampoli M, Whitelaw A, et al
    Pneumocystis Pneumonia in South African Children With and Without Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy.
    Pediatr Infect Dis J. 2010.
    PubMed     Text format     Related articles    Abstract available


    Vaccine

  47. HARANDI AM , Medaglini D, Shattock RJ
    Vaccine adjuvants: A priority for vaccine research.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available

  48. VAN-DUNEM JC , Alencar LC, Rodrigues LC, Albuquerque MD, et al
    Sensitivity and specificity of BCG scar reading among HIV-infected children.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available

  49. SEGAT L , Brandao LA, Guimaraes RL, Pontillo A, et al
    Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available


    Virology

  50. RESZKA N , Zhou C, Song B, Sodroski JG, et al
    Simian TRIM5alpha proteins reduce replication of herpes simplex virus.
    Virology. 2010.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: